null
ChEBI ID: 46769
| Member | Definition | Role |
|---|---|---|
| tosufloxacin | A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively. | 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 26 (16.15) | 18.7374 |
| 1990's | 62 (38.51) | 18.2507 |
| 2000's | 44 (27.33) | 29.6817 |
| 2010's | 23 (14.29) | 24.3611 |
| 2020's | 6 (3.73) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 16 (9.41%) | 5.53% |
| Reviews | 8 (4.71%) | 6.00% |
| Case Studies | 17 (10.00%) | 4.05% |
| Observational | 1 (0.59%) | 0.25% |
| Other | 128 (75.29%) | 84.16% |